Intrinsic Imaging
← All press releases

February 1, 2016

Intrinsic Imaging's ISO Certified Quality Management System to be Featured at the Imaging in Clinical Trials Event

Todd A. Joron, President and COO, invited to present "Medical Imaging — Advantages of an ISO Certified Quality Management System" at CBI's Imaging in Clinical Trials, March 29–30, 2016, Philadelphia.

Download the PDF

Bolton, MA and San Antonio, TX, February 1, 2016 — Intrinsic Imaging, an FDA audited, ISO 9001, 13485 and 22301 certified medical imaging core lab specializing in providing services for Phase I-IV clinical trials, announced today that Todd A. Joron, BSc., MBA, President and COO is an invited speaker at the upcoming Imaging in Clinical Trials event on March 29-30, 2016 at the Wyndham Philadelphia Historic District Hotel.

Mr. Joron will join other industry leading speakers from Bayer, Eisai, Gilead, Merck, Merrimack Pharmaceuticals, and Shire.

Certified by the British Standards Institution (BSI), one of the world's largest, reputable and respected certification bodies in the world, Intrinsic Imaging's quality management system is ISO 9001, 13485 and 22301 certified specifically for optimizing the quality of imaging data obtained in pharmaceutical and medical device clinical trials.

Mr. Joron, a 30-year industry veteran, will present a session titled "Medical Imaging — Advantages of an ISO Certified Quality Management System" at 2:15pm on March 29th, 2016. This session will review the advantages of having an ISO 9001, ISO 13485 and ISO 22301 certified quality management system designed specifically for managing all aspects of imaging conducted during clinical and medical device trials. Case studies will also be presented and examined.

Please join Mr. Joron and Craig Pennington, Vice President, to learn how Intrinsic Imaging's ISO Certified Quality Management System can benefit your next clinical trial.

About CBI's Imaging In Clinical Trials

Imaging in Clinical Trials is dedicated to assisting sponsors in optimizing the quality of imaging data obtained in clinical trials intended to support approval of drugs and biological products. Attendees will gain insights into imaging, display, archiving and interpretation best practices when imaging is used to assess a trial's primary endpoint or a component of that endpoint.

About Intrinsic Imaging, LLC

Intrinsic Imaging is a full-service medical imaging core lab providing comprehensive services in support of Phase I-IV clinical trials and Class I, II, III medical device trials. Intrinsic Imaging is also a world leader in conducting Artificial Intelligence studies. With its team of more than 750 board-certified and fellowship-trained physicians, Intrinsic Imaging’s team has sub-specialization in all therapeutic areas, including Cardiovascular, Central Nervous System, Gastroenterology, Musculoskeletal, Oncology and Ophthalmology. Certified by the British Standards Institution (BSI), Intrinsic Imaging is the only company in the world to hold five ISO certifications specifically for providing imaging core lab services on clinical trials. For more information, please visit www.IntrinsicImaging.com.

Get Our Announcements by Email

Receive Intrinsic Imaging press releases as soon as they are issued.

Contact: